Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by fatboy92on Jul 25, 2014 2:12am
195 Views
Post# 22780849

RE:RE:We need some changes...

RE:RE:We need some changes...I agree that was one heck of a post JDStox , said from the heart and most probably what many here are thinking. Do you send some of your best comments, criticism on to BioAsis?

The recent run was mostly I believe ICO shareholders dumping their loser and piling into what they believe could be a game changer and make up for the terrible beating that was handed out to almost anyone that held ICO shares myself included. It wasn't the new IR or the new CFO, I'm really not sure what BioAsis was thinking of when hiring these people, it doesn't look like they have had any influence at all! Maybe they were just bringing in some good buddies and old friends to take a ride.  
But here we go, on a ride down!  The new buyers have dried up. We all wanted to get in at the same time and drove the price near the 52 week high.

Where are the  brokerages firms, portfolio and fund managers coming in to swoop up low hanging fruit? Where is the promotion of the company? Hopefully all this is being done behind the scenes? I'm not sure if any management even looks at this board? Hopefully they do and get a sense of shareholder frustration.

ps...Maybe I wouldn't be as disappointed  if I had bought when I first looked at BTI when trading at .46 or if I hadn't sold the shares I bought in the low .80's for a 50% profit. But now to see my most recent shares in the red it's a little unnerving. However I do believe that this could be a real game changer for anybody who suffers from many of the diseases that will be helped by getting the proper drugs throughout the BBB and want the best people in position to take this to the medical and investors community for all to take advantage off.
Bullboard Posts